Tag: CSF1R inhibitor

Home / CSF1R inhibitor

Categories

Vimseltinib is approved by the USFDA for symptomatic tenosynovial giant cell tumor

On February 14, 2025, the Food and Drug Administration sanctioned vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cel...
csf1r-inhibitor

Scan the code